FAPMA Activities


In 2012, the Africa Heads of State through the African Union (AU) endorsed the Pharmaceutical Manufacturing Plan for Africa Business Plan (PMPA BP). The core objective of the PMPA BP is to develop a competitive and enduring integrated pharmaceutical manufacturing industry in Africa, able to respond to the continent’s need for access to secure and reliable supply of quality, safe and efficacious affordable medicines. By supporting local pharmaceutical manufacturing, the continent will contribute towards:
  • A sustainable supply of quality essential medicines
  • Improved public health outcomes
  • Industrial and economic development.
The vision and objectives of the PMPA BP provide a strong rallying point for FAPMA. In line with the generic solutions identified in the PMPA BP, FAPMA has identified the following priorities that will contribute towards the realisation of both the PMPA BP and the vision of FAPMA:

Priority One:

Proactively advocating for an enabling environment for the growth of the local production in Africa through policy changes and time limited incentives. The Africa-based pharmaceutical manufacturing sector promotes investments and creates knowledge based jobs, thereby improving competitiveness as well as public health. FAPMA is committed to the recognition of the industry as a continental asset and to have policies that will contribute towards its growth.

Priority Two:

Promotion of higher Good Manufacturing practices and efficiencies in production. FAPMA is committed to the production of quality, efficacious and affordable medicines that meet international standards. FAPMA is committed to the attainment of the highest Good Manufacturing Practice, equivalent to WHO standards.

Priority Three:

Contributing and facilitating knowledge and skills development; and technology transfer. FAPMA is committed to setting and achieving high standards for prioritised skills sets within the industry. FAPMA is committed to ensuring that personnel with the relevant skills are available to meet the needs of the industry.

Priority Four:

Contributing towards the realisation of the regulatory harmonisation vision in Africa. FAPMA recognises that a harmonised regulatory environment will lead to the growth of the industry, leading to increase access to affordable, quality-assured medicines in Africa.

Priority Five:

Supporting the development of partnerships or business linkage platforms for access to markets, funding and technology. FAPMA recognises the need for partnerships to build capacity to realise their vision of contributing towards access to quality affordable medicines in Africa. FAPMA is committed to facilitating opportunities for those partnerships and linkages.

Priority Six:

Supporting and strengthening regional manufacturing associations: African solutions to African healthcare challenges can be found through strong regional pharmaceutical manufacturing associations. FAPMA is committed to implementing activities and programmes that will strengthen the regional Africa-based pharmaceutical manufacturers associations.
  • Address:77 Meintjies Street, Sunnyside,
    0132, South Africa
  • Telephone: +27 12 394 5546
    Fax: +27 86 542 2028
    Email: info@fapma.org

Supported by : United Nations Industrial Development Organization (UNIDO)

Supported by the United Nations Industrial Development Organization (UNIDO)